Showing results (2901-2910 of 3,353) with videos related to
Sort By:
Pageof 336
Pharmacoeconomics|December 18, 2002
Potential costs and effects of the National Service Framework for Coronary Heart Disease in the UKVenanzio VellaPharmacoeconomics|February 1, 2003
Bedside rapid flu test and zanamivir prescription in healthy working adults: a cost-benefit analysisMichaël Schwarzinger, Bruno Housset, Fabrice CarratPharmacoeconomics|January 5, 2002
Economic evaluation of collagenase-containing ointment and hydrocolloid dressing in the treatment of pressure ulcersE Müller, M W van Leen, R BergemannPharmacoeconomics|January 31, 2002
Antihypertensive treatment with and without benazepril in patients with chronic renal insufficiency: a US economic evaluationThomas J Hogan, William J Elliott, Arnold H Seto, et al.Pharmacoeconomics|January 31, 2002
Economic impact of low dose polyethylene glycol 3350 plus electrolytes compared with lactulose in the management of idiopathic constipation in the UKAngela H Christie, Pearl Culbert, Julian F GuestPharmacoeconomics|December 12, 2001
Which antifungal agent for onychomycosis? A pharmacoeconomic analysisV N Joish, E P ArmstrongPharmacoeconomics|December 12, 2001
Quality-of-life assessment in patients with benign prostatic hyperplasia: effects of various interventionsJ E Batista-Miranda, M D Diez, P A Bertrán, et al.Pharmacoeconomics|December 12, 2001
Incremental cost-effectiveness analysis comparing rofecoxib with nonselective NSAIDs in osteoarthritis: Ontario Ministry of Health perspectiveJ K Marshall, J M Pellissier, C L Attard, et al.Pharmacoeconomics|December 12, 2001
Economic evaluations during early (phase II) drug development: a role for clinical trial simulations?D A Hughes, T WalleyPharmacoeconomics|December 12, 2001
Cost effectiveness of treatment options in advanced breast cancer in the UKR E Brown, J Hutton, A BurrellPageof 336